Triptodur® (triptorelin) for extended-release injectable suspension is an FDA approved medication distributed in the US by Azurity Pharmaceuticals, Inc. Azurity is a privately held, specialty pharmaceutical company that focuses on developing innovative products that meet the needs of patients with underserved conditions. For more information regarding Triptodur® (triptorelin) for extended release injectable suspension, visit www.triptodur.com/hcp or send email inquiries to email@example.com.
Triptodur® is manufactured by Debiopharm Research & Manufacturing SA on behalf of Arbor Pharmaceuticals, LLC, a subsidiary of Azurity Pharmaceuticals, Inc. Triptodur® is a registered trademark of Debiopharm International SA.
8 Cabot Road, Suite 2000
Woburn, MA 01801
Brief summary of the materials and/or video content:
Triptodur Administration Video: Watch a step-by-step video on how to administer Triptodur.
Click here to watch the Triptodur Administration Video: https://vimeo.com/364073964/aa6a2a8c72
Click here to watch the Triptodur Administration Video:
Have questions? Please contact:
Enter the MAP Spotlight Raffle